From Wikipedia, the free encyclopedia
Large neutral amino acids transporter small subunit 2 is a protein that in humans is encoded by the SLC7A8 gene.[1][2][3]
See also[edit]
References[edit]
- ^ Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, Manzoni M, Incerti B, Pepe A, Andria G, Ballabio A, Sebastio G (Mar 1999). "SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance". Nat Genet 21 (3): 297–301. doi:10.1038/6815. PMID 10080183.
- ^ Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, Lloberas J, Zorzano A, Palacin M (Aug 1999). "Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids". J Biol Chem 274 (28): 19738–44. doi:10.1074/jbc.274.28.19738. PMID 10391915.
- ^ "Entrez Gene: SLC7A8 solute carrier family 7 (cationic amino acid transporter, y+ system), member 8".
Further reading[edit]
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Rossier G, Meier C, Bauch C et al. (2000). "LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine". J. Biol. Chem. 274 (49): 34948–54. doi:10.1074/jbc.274.49.34948. PMID 10574970.
- Bassi MT, Sperandeo MP, Incerti B et al. (2000). "SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family". Genomics 62 (2): 297–303. doi:10.1006/geno.1999.5978. PMID 10610726.
- Bröer A, Friedrich B, Wagner CA et al. (2001). "Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains". Biochem. J. 355 (Pt 3): 725–31. PMC 1221788. PMID 11311135.
- Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Liu X, Charrier L, Gewirtz A et al. (2003). "CD98 and intracellular adhesion molecule I regulate the activity of amino acid transporter LAT-2 in polarized intestinal epithelia". J. Biol. Chem. 278 (26): 23672–7. doi:10.1074/jbc.M302777200. PMID 12716892.
- Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Li S, Whorton AR (2005). "Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols". J. Biol. Chem. 280 (20): 20102–10. doi:10.1074/jbc.M413164200. PMID 15769744.
- Kühne A, Kaiser R, Schirmer M et al. (2007). "Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan". Pharmacogenet. Genomics 17 (7): 505–17. doi:10.1097/FPC.0b013e3280ea77cd. PMID 17558306.
|
|
|
|
By group
|
|
|
SLC1–10
|
|
| (1): |
|
|
| (2): |
|
|
| (3): |
|
|
| (4): |
|
|
| (5): |
|
|
| (6): |
|
|
| (7): |
|
|
| (8): |
|
|
| (9): |
|
|
| (10): |
|
|
|
|
|
SLC11–20
|
|
| (11): |
|
|
| (12): |
|
|
| (13): |
|
|
| (14): |
|
|
| (15): |
|
|
| (16): |
|
|
| (17): |
|
|
| (18): |
|
|
| (19): |
|
|
| (20): |
|
|
|
|
|
SLC21–30
|
|
| (21): |
|
|
| (22): |
|
|
| (23): |
|
|
| (24): |
|
|
| (25): |
|
|
| (26): |
|
|
| (27): |
|
|
| (28): |
|
|
| (29): |
|
|
| (30): |
|
|
|
|
|
SLC31–40
|
|
| (31): |
|
|
| (32): |
|
|
| (33): |
|
|
| (34): |
|
|
| (35): |
|
|
| (36): |
|
|
| (37): |
|
|
| (38): |
|
|
| (39): |
|
|
| (40): |
|
|
|
|
|
SLC41–48
|
|
| (41): |
|
|
| (42): |
|
|
| (43): |
|
|
| (44): |
|
|
| (45): |
|
|
| (46): |
|
|
| (47): |
|
|
| (48): |
|
|
|
|
|
|
|
|
|
|
|
|
|
Index of cells
|
|
| Description |
|
|
| Disease |
|
|
|
